BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Ophthalmology 2006;90:223-228; doi:10.1136/bjo.2005.078014
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Georges, P
Right arrow Articles by Madigan, M C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Georges, P
Right arrow Articles by Madigan, M C

EXTENDED REPORT

Müller cell expression of glutamate cycle related proteins and anti-apoptotic proteins in early human retinal development

P Georges1, E E Cornish1, J M Provis1,2, M C Madigan1

1 Save Sight Institute, University of Sydney, NSW 2006, Australia
2 Research School of Biological Sciences, Australian National University, ACT 2605 Australia

Correspondence to:
Correspondence to:
Michele C Madigan
Save Sight Institute, GPO Box 4337, Sydney NSW 2001 Australia; michele{at}eye.usyd.edu.au

Aims: The distribution of glutamate cycle related proteins (glutamine synthetase (GS) and GLAST) and anti-apoptotic proteins (Bcl-2 and Bcl-X) was investigated in Müller cells during early human retinal development, relative to the onset of expression of synaptophysin, a presynaptic vesicle protein.

Methods: Using frozen sections of human fetal eyes (13–22 weeks gestation) (n = 10), Bcl-2, Bcl-X, GS, GLAST, and synaptophysin immunoreactivities (IR) were imaged using fluorescence microscopy and plotted as a function of eccentricity from the incipient fovea. Frozen sections of adult human retina (n = 4) were immunolabelled with antibodies to Bcl-2 and Bcl-X.

Results: Müller cell immunoreactivity for GS, GLAST, and Bcl-2 was initially detected in the incipient fovea, and then at more peripheral locations with increasing age. Synaptophysin-IR appeared earlier than all other target proteins. Within the synaptophysin-IR region, mature (differentiated) Müller cells expressed both Bcl-2 and Bcl-X-IR from 13 weeks gestation, ahead of GS-IR and GLAST-IR that were first seen at 14 weeks gestation. Additionally, from as early as 13 weeks gestation, ganglion cells and immature neuronal progenitor cells across the entire retina expressed Bcl-2-IR and Bcl-X-IR, respectively. In adult retina, ganglion cells and some bipolar cells expressed Bcl-X but not Bcl-2.

Conclusion: Müller cells express Bcl-2 and Bcl-X after synaptogenesis has commenced, but before the onset of GS and GLAST expression, suggesting a protective role for these proteins in Müller cells during the onset of glutamatergic transmission in early human retinal development.


Abbreviations: CRALBP, cellular retinaldehyde binding protein; EAAT1, excitatory amino acid transporter 1; GCL, ganglion cell layer; GLAST, L-glutamate-L-aspartate transporter; GS, glutamine synthetase; INL, inner nuclear layer; IPL, inner plexiform layer; IR, immunoreactivities; PBS, phosphate buffered saline

Keywords: cell survival; glutamine synthetase; l-glutamate-l-aspartate transporter; Bcl-2 family proteins; synaptogenesis




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
A Allende, M C Madigan, and J M Provis
Endothelial cell proliferation in the choriocapillaris during human retinal differentiation
Br. J. Ophthalmol., August 1, 2006; 90(8): 1046 - 1051.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.